NCT07289607

Brief Summary

Cervical radiculopathy is characterized by pain, sensory disturbances, and impaired neuromuscular control due to nerve root compression. Proprioception dysfunction is often an overlooked component of this condition and can affect balance, posture, and motor control. TECAR (Transfer of Energy Capacitive and Resistive) therapy is a form of deep heat electrotherapy known to improve tissue perfusion and neuromuscular function. Although TECAR is widely used for pain relief and mobility, its role in improving proprioception remains under-investigated, especially in cervical conditions. This study aims to bridge this gap by assessing proprioceptive outcomes in patients with cervical radiculopathy receiving TECAR therapy.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 4, 2025

Completed
13 days until next milestone

First Posted

Study publicly available on registry

December 17, 2025

Completed
15 days until next milestone

Study Start

First participant enrolled

January 1, 2026

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 5, 2026

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

April 5, 2026

Completed
Last Updated

December 18, 2025

Status Verified

December 1, 2025

Enrollment Period

2 months

First QC Date

December 4, 2025

Last Update Submit

December 17, 2025

Conditions

Keywords

TECAR , radiculopathy , Proprioception

Outcome Measures

Primary Outcomes (2)

  • proprioception function

    assessment of proprioception functions via CROM

    Baseline

  • Cervical ROM

    ROM assessment via CROM

    Baseline

Study Arms (2)

study group

ACTIVE COMPARATOR

Receives TECAR therapy in addition to standard physiotherapy.

Device: TECAR therapy

Control group

SHAM COMPARATOR

Receives sham TECAR

Device: Sham TECAR therapy

Interventions

TECAR Therapy A form of radiofrequency-based deep thermotherapy that delivers energy into tissues using frequencies between 300 kHz and 1.2 MHz. It heats from the inside out, giving deeper and more controlled thermal effects than superficial heat modalities.

study group

TECAR Therapy a form of radiofrequency-based deep thermotherapy that delivers energy into tissues using frequencies between 300 kHz and 1.2 MHz. It heats from the inside out, giving deeper and more controlled thermal effects than superficial heat modalities.

Control group

Eligibility Criteria

Age30 Years - 45 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Diagnosed cervical radiculopathy confirmed by clinical and radiological findings
  • Age 30-40 years
  • Pain duration \> 4 weeks

You may not qualify if:

  • Cervical fracture or surgery
  • Vestibular disorders
  • Rheumatologic or neurological diseases
  • Cognitive impairment or pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Private Clinic

Al Mansurah, 35511, Egypt

Location

Related Publications (1)

  • Bameri A, Yassin M, Salehi R, Mansour Sohani S. The Effects of Manual Therapy with TECAR Therapy, on Pain, Disability and Range of Motion in Women with Non-specific Chronic Neck Pain. Med J Islam Repub Iran. 2024 Sep 17;38:107. doi: 10.47176/mjiri.38.107. eCollection 2024.

    PMID: 39781327BACKGROUND

MeSH Terms

Conditions

Radiculopathy

Condition Hierarchy (Ancestors)

Peripheral Nervous System DiseasesNeuromuscular DiseasesNervous System Diseases

Central Study Contacts

ibrahim A abu ella, Phd

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
the patient in control group will receive sham TECAR therapy in addition to physical therapy exercise program.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer

Study Record Dates

First Submitted

December 4, 2025

First Posted

December 17, 2025

Study Start

January 1, 2026

Primary Completion

March 5, 2026

Study Completion

April 5, 2026

Last Updated

December 18, 2025

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

CONFIDENTIALITY OF THE RESEARCH

Locations